Richa Parikh, MD

Background

A hematologist with expertise in the treatment of multiple myeloma, Richa Parikh, MD, is an attending physician practicing at Winship Cancer Institute at Emory Midtown. Dr. Parikh serves as an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Prior to joining Emory, she was on faculty and served as an academic hospitalist on the multiple myeloma service at University of Arkansas for Medical Sciences Myeloma Center in Little Rock, Arkansas.

Dr. Parikh received her medical degree from the Grant Government Medical College & Sir J.J. Group of Hospitals in Mumbai, India. She completed her internal medicine residency at University of Arkansas for Medical Sciences in Little Rock, Arkansas. She then completed her hematology and medical oncology fellowship at Karmanos Cancer Institute/ Wayne State University in Detroit, Michigan.

Titles & Roles

• Assistant Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Hematology/Oncology, 2024

  Wayne State Univ./Detroit Med. Ctr.
• Residency, Internal Medicine, 2019

  University of Arkansas for Medical Sciences
• Medical Education, MD, 2014

  Grant Government Medical College

Board Certifications

• Medical Oncology

  American Board of Internal Medicine, 2023
• Internal Medicine

  American Board of Internal Medicine, 2019
• Hematology

  American Board of Internal Medicine,

Professional Memberships

• American Society of Hematology
• American Society of Oncology
• American College of Physicians

Research

Dr. Parikh's major research focus is evaluating the impact of modifiable lifestyle factors like obesity, diabetes mellitus, diet, and gut microbiome on myeloma risk. Her other research interests include novel therapies for myeloma, autologous stem cell transplantation, and utilizing minimal residual disease testing to guide treatment strategies in plasma cell disorders.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.